IKBKB (Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta), also known as IKKβ, encodes a critical serine/threonine protein kinase that serves as the catalytic core of the IKK complex. This complex is essential for activating the NF-κB transcription factor, which plays a central role in inflammation, immune response, cell survival, and neurodegeneration. [1]
IKKβ is the catalytic subunit of the IκB kinase (IKK) complex, which also includes IKKα (CHUK) and IKKγ (NEMO). The IKK complex phosphorylates IκBα, leading to its ubiquitination and degradation, thereby releasing NF-κB to translocate to the nucleus and activate target genes. Dysregulation of IKKβ/NF-κB signaling is implicated in chronic neuroinflammation, a hallmark of neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and ALS. [2]
| Property | Value | [3]
|----------|-------| [4]
| Gene Symbol | IKBKB | [5]
| Alternate Symbols | IKKβ, IKK2 | [6]
| Full Name | Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta | [7]
| Chromosomal Location | 8p11.21 | [8]
| NCBI Gene ID | 3551 |
| Ensembl ID | ENSG00000105220 |
| UniProt ID | O14920 |
| RefSeq mRNA | NM_001190 |
| Protein Length | 756 amino acids |
The IKKβ protein contains several functional domains:
IKKβ is the primary kinase responsible for canonical NF-κB activation:
IKBKB is widely expressed across tissues:
IKKβ-mediated NF-κB activation plays a complex role in AD:
In PD, IKKβ contributes to:
Several IKKβ inhibitors have been developed:
| Compound | Stage | Notes |
|---|---|---|
| Bay 11-7082 | Preclinical | Irreversible IKKβ inhibition |
| MLN120B | Preclinical | Selective IKKβ inhibitor |
| PS-1145 | Preclinical | Blocks NF-κB activation |
| AC-907 | Research | Brain-penetrant IKKβ inhibitor |
The study of Ikkbeta Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Mercurio F, Murray BW, Shevchenko A, et al. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science. 1997. ↩︎
Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol. 2000. ↩︎
Hayden MS, Ghosh S. Signaling to NF-κB. Genes Dev. 2004. ↩︎
Ghosh S, Karin M. Missing pieces in the NF-κB puzzle. Cell. 2002. ↩︎
Karin M. How NF-κB is activated: the role of the IκB kinase (IKK) complex. Oncogene. 1999. ↩︎
Chen J, Chen ZJ. Regulation of NF-κB by ubiquitination. Curr Opin Immunol. 2013. ↩︎
Kaltschmidt B, Kaltschmidt C. NF-κB in the nervous system. Cold Spring Harb Perspect Biol. 2009. ↩︎
Mattson MP, Meffert MK. Roles for NF-κB in the nervous system: insights from experiments and models. Cell Mol Life Sci. 2006. ↩︎